TRON Group Inc. (TGRP)
OTCMKTS · Delayed Price · Currency is USD
0.0355
0.00 (0.00%)
At close: Nov 4, 2026
TRON Group Market Cap
TRON Group has a market cap or net worth of $6.53 million as of November 5, 2026. It is the 43,590th most valuable company in the world and the 5,790th biggest in the United States. Its market cap has decreased by 28.71% in one year.
Market Cap
6.53M
Enterprise Value
n/a
Revenue
1.01M
Global Rank
Country Rank
#5,790 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 21, 2018, TRON Group's market cap has decreased from 232.00M to 6.53M, a decrease of -97.18%. That is a compound annual growth rate of -33.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 6.53M | -21.11% |
| Dec 30, 2025 | 8.28M | -35.34% |
| Dec 30, 2024 | 12.81M | -95.09% |
| Dec 27, 2021 | 261.00M | 71.71% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 7.64M |
| Zeo ScientifiX | 7.60M |
| Oncotelic Therapeutics | 7.59M |
| EOM Pharmaceuticals Holdings | 6.59M |
| VitaSpring Biomedical | 6.58M |
| Curative Biotechnology | 5.94M |
| OSR Health | 5.62M |
| Adaptimmune Therapeutics | 5.30M |